Shilpa Medicare Limited
Shilpa Medicare Incorporated in 1987 manufactures niche APIs, intermediates, and formulations and also undertakes contract research and manufacturing service for some of its customers. The company’s formulation products consist of 16 injectable dosage forms, 19 oral solid dosage forms under SML and 13 formulations under SML’s wholly owned subsidiary Shilpa Therapeutics.
What Shilpa files
- Important41
- Updates40
- Others36
- Investor Meet26
- Board Meeting14
- PPTs8
Shilpa Medicare Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 11, 2026
Shilpa Medicare Limited has informed the Exchange about Copy of Newspaper Publication
Shilpa Medicare Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 11, 2026
Shilpa Medicare Limited has informed the Exchange regarding Appointment of Mr Dr. Uday N. Harle as Chief Executive Officer (CEO) of Shilpa Biologicals Private Limited, a Wholly Owned Subsidiary of Shilpa Medicare Limited w.e.f. August 03, 2026. (Senior Managerial Personnel).
Shilpa Medicare Limited has informed the Exchange about the resignation of Dr. Sridevi Khambhampaty, as Chief Executive Officer (CEO) of Shilpa Biologicals Private Limited, a material subsidiary of Shilpa Medicare Limited.